Korea’s New Health Minister: ‘Golden Time For The Country To Become A Biopharma Leader’

Vows To Reform, Improve Regulations As Part Of Biopharma Growth Strategy

 
• By Jung Won Shin
  
Korea's bio innovation roundtable
The group discussed five-year goals on biopharma exports, blockbuster drugs, and clinical trials. (Jung Won Shin)

More from R&D

More from Asia